INTECH Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131K Sell
31,163
-7,880
-20% -$30.4K ﹤0.01% 1891
2026
Q1
$137K Sell
39,043
-32,530
-45% -$133K ﹤0.01% 1836
2025
Q4
$241K Sell
71,573
-621
-0.9% -$1.61K ﹤0.01% 1874
2025
Q3
$94.6K Sell
72,194
-15,593
-18% -$16.1K ﹤0.01% 2283
2025
Q2
$63K Hold
87,787
﹤0.01% 2391
2025
Q1
$129K Buy
87,787
+30,543
+53% +$72.7K ﹤0.01% 2248
2024
Q4
$254K Buy
57,244
+13,205
+30% +$53.6K ﹤0.01% 1918
2024
Q3
$181K Buy
+44,039
New +$237K ﹤0.01% 1758

Other funds holding IRWD

INTECH Investment Management's IRWD Position: Q2 2026 in Review

INTECH Investment Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 20% in Q2 2026, selling an estimated $30.4K and leaving 31,163 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1891.

INTECH Investment Management first reported a position in IRWD in Q3 2024 and has held it in 8 quarters since. The position peaked at $254K in Q4 2024. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • INTECH Investment Management held 31,163 shares of Ironwood Pharmaceuticals worth $131K as of Q2 2026.
  • INTECH Investment Management sold 7,880 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $30.4K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1891 holding.
  • INTECH Investment Management first reported a position in Ironwood Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Ironwood Pharmaceuticals position peaked at $254K in Q4 2024.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.